Rubin MA - Search Results

1

Aggressive variants of castration-resistant prostate cancer.

Beltran H, Tomlins S, Aparicio A, Arora V, Rickman D, Ayala G, Huang J, True L, Gleave ME, Soule H, Logothetis C, Rubin MA. Beltran H, et al. Among authors: rubin ma. Clin Cancer Res. 2014 Jun 1;20(11):2846-50. doi: 10.1158/1078-0432.CCR-13-3309. Epub 2014 Apr 11. Clin Cancer Res. 2014. PMID: 24727321 Free PMC article. Review.

2

Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma.

Bassily NH, Vallorosi CJ, Akdas G, Montie JE, Rubin MA. Bassily NH, et al. Among authors: rubin ma. Am J Clin Pathol. 2000 Mar;113(3):383-8. doi: 10.1309/G1RA-EU9X-X6VV-3W79. Am J Clin Pathol. 2000. PMID: 10705819

3

Rapid ("warm") autopsy study for procurement of metastatic prostate cancer.

Rubin MA, Putzi M, Mucci N, Smith DC, Wojno K, Korenchuk S, Pienta KJ. Rubin MA, et al. Clin Cancer Res. 2000 Mar;6(3):1038-45. Clin Cancer Res. 2000. PMID: 10741732

4

Posttranslational truncation and inactivation of human E-cadherin distinguishes prostate cancer from matched normal prostate.

Rashid MG, Sanda MG, Vallorosi CJ, Rios-Doria J, Rubin MA, Day ML. Rashid MG, et al. Among authors: rubin ma. Cancer Res. 2001 Jan 15;61(2):489-92. Cancer Res. 2001. PMID: 11212238

5

Activated in prostate cancer: a PDZ domain-containing protein highly expressed in human primary prostate tumors.

Chaib H, Rubin MA, Mucci NR, Li L, Taylor JMG, Day ML, Rhim JS, Macoska JA. Chaib H, et al. Among authors: rubin ma. Cancer Res. 2001 Mar 15;61(6):2390-4. Cancer Res. 2001. PMID: 11289102

6

Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis.

Rubin MA, Kleter B, Zhou M, Ayala G, Cubilla AL, Quint WG, Pirog EC. Rubin MA, et al. Am J Pathol. 2001 Oct;159(4):1211-8. doi: 10.1016/S0002-9440(10)62506-0. Am J Pathol. 2001. PMID: 11583947 Free PMC article.

7

Loss of heterozygosity of the putative prostate cancer susceptibility gene HPC2/ELAC2 is uncommon in sporadic and familial prostate cancer.

Wu YQ, Chen H, Rubin MA, Wojno KJ, Cooney KA. Wu YQ, et al. Among authors: rubin ma. Cancer Res. 2001 Dec 15;61(24):8651-3. Cancer Res. 2001. PMID: 11751379

8

Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer.

Rhodes DR, Barrette TR, Rubin MA, Ghosh D, Chinnaiyan AM. Rhodes DR, et al. Among authors: rubin ma. Cancer Res. 2002 Aug 1;62(15):4427-33. Cancer Res. 2002. PMID: 12154050

9

Dysregulation of the annexin family protein family is associated with prostate cancer progression.

Xin W, Rhodes DR, Ingold C, Chinnaiyan AM, Rubin MA. Xin W, et al. Among authors: rubin ma. Am J Pathol. 2003 Jan;162(1):255-61. doi: 10.1016/S0002-9440(10)63816-3. Am J Pathol. 2003. PMID: 12507908 Free PMC article.

10

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells.

Kleer CG, Cao Q, Varambally S, Shen R, Ota I, Tomlins SA, Ghosh D, Sewalt RG, Otte AP, Hayes DF, Sabel MS, Livant D, Weiss SJ, Rubin MA, Chinnaiyan AM. Kleer CG, et al. Among authors: rubin ma. Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11606-11. doi: 10.1073/pnas.1933744100. Epub 2003 Sep 19. Proc Natl Acad Sci U S A. 2003. PMID: 14500907 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

862 results

Search Page